CClinicalTrials.gg
CompletedNCT03458741SupercompUpdated Mar 8, 2018

How is Glycogen Supercompensation Regulated in Human Skeletal Muscle

An interventional study of Glycogen Supercompensation in Glycogen Depletion and Insulin Sensitivity, sponsored by University of Copenhagen. Completed at 1 site in Denmark. Open to male participants aged 25 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-08.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
9
Ages
25 Years to 30 Years
Sex
Male
01

Study summary

Nine healthy, moderately fit male volunteers participated in the study. The subjects gave written informed consent after having been informed of any possible risk and discomfort associated with the study. The study was approved by the regional ethics committee in Denmark (Journal number: H-4-2013-071) and performed in accordance with the Declarations of Helsinki II.

All subjects underwent 3 clinical investigations (day 1, day 2 and day 5) during a 5 day glycogen supercompensation regime. The subjects were asked to refrain from physical activity and to eat a controlled diet containing 60% carbohydrates (CHO) for 4 days prior to the initial experiments.

Upon arrival at the laboratory on day 1, the subjects performed one-legged knee extensor exercise for 1 hour at 80% of PWL interspersed by 5 min bouts at 90% of PWL. This was followed by interval exercise until exhaustion containing 4 min bouts starting at 100% PWL followed by 1 min at 50% of PWL. Upon cessation of exercise the subjects showered and rested in the supine position for 4 hours. Then a 120 min hyperinsulinemic euglycemic clamp was initiated by a bolus insulin injection (9.0 mU/kg, Actrapid, Novo Nordisk, Denmark) followed by continuous insulin infusion (1.42 mU/kg/min insulin) reaching a level of plasma insulin around 100 µU/mL (n=9). At least 2 hours before the insulin clamp, catheters were placed in both femoral, one antecubital and one dorsal hand vein. A heat pad was placed around the lower part of the arm and hand in order to "arterialize" blood drawn from the hand vein. Substrate uptake/release across the legs was calculated by multiplying the arterial-venous (AV) difference in blood substrate concentration by femoral arterial blood flow (measured by ultrasound, Philips DICOM). Blood glucose levels were maintained at the euglycemic predefined target by continuously adjusting the glucose infusion rate (GIR) (20% glucose solution; Fresenius Kabi, Sweden). Concurrent measures of substrate AV differences and blood flow were performed every 20 min. Muscle biopsies from m. vastus lateralis were obtained under local anaesthesia (3-5 ml of Xylocaine, 20 mg/ml.) in the basal- and insulin-stimulated state (120 min) by use of needle biopsy technique. Muscle specimen were frozen within 20 sec in liquid nitrogen and stored at -80°C for further analysis. A new incision was made for every biopsy and spaced 4-5 cm apart.

This insulin clamp procedure in combination with basal and insulin stimulated muscle biopsies was repeated in the rested state (without prior exercise) on day 2 and day 5. The subjects arrived in the morning in the overnight fasted state at day 1, day 2 and day 5. During the 5 day supercompensation regime the subjects were provided a predefined isocaloric diet containing 80% carbohydrates, 10% fat and 10% proteins. All food items were handle out to the subjects and compliance of the diet regime was ensured by survey.

02

Conditions studied

  • Glycogen Depletion
  • Insulin Sensitivity

Browse trials for

03

Who can participate

Ages eligible
25 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • male
  • BMI between BMI 20-25 kg/m2
  • healthy and not using medication
  • not smoking
  • habitual physical activity level of 2 - 6 hours pr. week
  • no incidence of diabetes, cardiovascular disease or other metabolic diseases in close family

Exclusion criteria

Exclusion Criteria:

  • female
  • BMI below 20 and above 25 kg/m2
  • using medication
  • smoking
  • habitual physical activity level below 2 h pr. week or above 6 hours pr. week
  • incidence of diabetes, cardiovascular disease or metabolic disease in close family
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
9 participants (actual)

Interventions

  • OtherGlycogen Supercompensation

    The subjects arrived in the morning in the overnight fasted state at day 1, day 2 and day 5. Upon arrival in the morning the subjects were given a meal corresponding to 5% of their daily energy intake (\~600-800 kJ). During the 5 day supercompensation regime the subjects were provided a predefined isocaloric diet containing 80% carbohydrates, 10% fat and 10% proteins. All food items were handle out to the subjects and compliance of the diet regime was ensured by survey.

05

What researchers measure

Primary outcomes

  1. Insulin action in skeletal muscle

    Insulin action in skeletal muscle was investigated during hyperinsulinemic euglycemic conditions by combining AV-difference with blood flow measurements.

    Time frame: 1 week

06

Study locations

1 site
  • Department of Nutrition, Exercise and Sports
    Copenhagen, Capital Region 2100, Denmark
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03458741
Lead sponsor
University of Copenhagen
Responsible party
Janne Rasmuss Hingst (PhD, University of Copenhagen) — Principal investigator
First posted
Mar 8, 2018
Start date
Sep 5, 2013
Primary completion
Dec 31, 2014
Completion
Dec 31, 2014
Last update
Mar 8, 2018

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion